Form 8-K - Current report:
SEC Accession No. 0001193125-24-008165
Filing Date
2024-01-16
Accepted
2024-01-16 09:01:55
Documents
12
Period of Report
2024-01-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d156888d8k.htm   iXBRL 8-K 29994
  Complete submission text file 0001193125-24-008165.txt   149020

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20240111.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20240111_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20240111_pre.xml EX-101.PRE 10807
6 EXTRACTED XBRL INSTANCE DOCUMENT d156888d8k_htm.xml XML 3216
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 24533834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)